Article Information
History
- December 28, 2020.
Article Versions
- Version 1 (May 1, 2020 - 08:54).
- Version 2 (May 18, 2020 - 08:57).
- Version 3 (June 17, 2020 - 13:17).
- You are viewing Version 4, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Author Information
- Ayya Keshet*,1,2,
- Amir Gavrieli*,1,2,
- Hagai Rossman*,1,2,
- Smadar Shilo*,1,2,3,
- Tomer Meir*,1,2,
- Tal Karady1,2,
- Amit Lavon1,2,
- Dmitry Kolobkov1,2,
- Iris Kalka1,2,
- Saar Shoer1,2,
- Anastasia Godneva1,2,
- Ori Cohen,
- Adam Kariv4,
- Ori Hoch4,
- Mushon Zer-Aviv4,
- Noam Castel4,
- Anat Ekka Zohar5,
- Angela Irony5,
- Benjamin Geiger2,
- Yuval Dor6,
- Dorit Hizi4,
- Ran Balicer7,
- Varda Shalev5,8 and
- Eran Segal1,2,*
- 1Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel
- 2Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel
- 3Pediatric Diabetes Unit, Ruth Rappaport Children’s Hospital, Rambam Healthcare Campus, Haifa, Israel
- 4The public knowledge workshop, 26 Saadia Gaon st. Tel Aviv
- 5Epidemiology and Database Research Unit, Maccabi Healthcare Services, Tel Aviv, Israel
- 6School of Medicine-IMRIC-Developmental Biology and Cancer Research, The Hebrew University, Jerusalem, Israel
- 7Clalit Research Institute, Clalit Health Services, Tel Aviv, Israel
- 8School of Public Health, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
- ↵*Corresponding author; email: eran.segal{at}weizmann.ac.il
↵* Equal contribution
Posted December 28, 2020.
The effect of a national lockdown in response to COVID-19 pandemic on the prevalence of clinical symptoms in the population
